Recall Z-0235-2018— Normand Informatique

Class II · Terminated

Class II FDA medical device recall by Normand Informatique, initiated 2017-10-16, terminated 2024-02-13. FDA's recall record names no specific 510(k) clearance for this event. Product: Remisol Advance Software (Driver Architect) Catalog Number B32129 The Remisol Advance Data Manager (Stand alone Data Management Systems) collects and manages data and manages workflows for connected systems. (i.e. Beckman Coulter Instruments, Automations, LIS &). It provides data analysis capabilities such as automatic results validation, delta checking, reflex testing, quality control, results editing and data management (i.e. archiving and restoration of patient results). The Remisol Advance system also offers workstation consolidation to three Beckman Coulter instruments from a single user console.. Reason: Beckman Coulter has identified that due to a software nonconformity in connection with a changed service setting Remisol could display wrong results..

Recalling firm
Normand Informatique
Classification
Class II
Status
Terminated
Initiated
2017-10-16
Terminated
2024-02-13
Firm location
Arras CEDEX, N/A, France

Product description

Remisol Advance Software (Driver Architect) Catalog Number B32129 The Remisol Advance Data Manager (Stand alone Data Management Systems) collects and manages data and manages workflows for connected systems. (i.e. Beckman Coulter Instruments, Automations, LIS &). It provides data analysis capabilities such as automatic results validation, delta checking, reflex testing, quality control, results editing and data management (i.e. archiving and restoration of patient results). The Remisol Advance system also offers workstation consolidation to three Beckman Coulter instruments from a single user console.

Reason for recall

Beckman Coulter has identified that due to a software nonconformity in connection with a changed service setting Remisol could display wrong results.

Data sourced from openFDA. This site is unofficial and independent of the FDA.